Effect of SGLT-2 inhibitor, dapagliflozin, on left ventricular remodeling in patients with type 2 diabetes and HFrEF [PDF]
Qianyu Fu+7 more
openalex +1 more source
Sacubitril/Valsartan vs. Standard Medical Therapy on Exercise Capacity in HFrEF Patients [PDF]
Alfonso Campanile+12 more
openalex +1 more source
Applicability and Clinical Utility of Framingham and NHANES criteria in HFrEF HFpEF and Combined HF
Dhanasegaran Sivanesan Egambaram+2 more
openalex +1 more source
Role of N-terminal pro-B type natriuretic peptide as a predictor of poor outcomes in patients with HFrEF receiving primary prevention implantable cardioverter-defibrillator therapy: a systematic review and dose–response meta-analysis [PDF]
Hawani Sasmaya Prameswari+10 more
openalex +1 more source
P240 SHORT–TERM EFFECT OF SGLT2I ON ECHOCARDIOGRAPHIC PARAMETERS IN HFREF PATIENTS TREATED WITH ARNI
Samanta Mazzetti+9 more
openalex +1 more source
Inward Displacement: A Novel Method of Regional Left Ventricular Functional Assessment for Left Ventriculoplasty Interventions in Heart Failure with Reduced Ejection Fraction (HFrEF) [PDF]
Romy R. M. J. J. Hegeman+6 more
openalex +1 more source
CILP-1 Is a Biomarker for Backward Failure and Right Ventricular Dysfunction in HFrEF [PDF]
Annika Weidenhammer+13 more
openalex +1 more source
Updated guidance from NICE on implantable defibrillators: does it work in real life? [PDF]
Cowie, MR
core +1 more source